Gregory Williams
2019 - Sevion Therapeutics
In 2019, Gregory Williams earned a total compensation of $2.7M as Chief Operating Officer at Sevion Therapeutics, a 55% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $165,000 |
---|---|
Option Awards | $1,758,250 |
Salary | $409,375 |
Stock Awards | $345,900 |
Other | $12,327 |
Total | $2,690,852 |
Williams received $1.8M in option awards, accounting for 65% of the total pay in 2019.
Williams also received $165K in non-equity incentive plan, $409.4K in salary, $345.9K in stock awards and $12.3K in other compensation.
Rankings
In 2019, Gregory Williams' compensation ranked 4,530th out of 13,971 executives tracked by ExecPay. In other words, Williams earned more than 67.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,530 | 68th |
Manufacturing | 1,690 | 70th |
Chemicals And Allied Products | 590 | 73rd |
Drugs | 496 | 74th |
Biological Products, Except Diagnostic Substances | 108 | 72nd |
Williams' colleagues
We found three more compensation records of executives who worked with Gregory Williams at Sevion Therapeutics in 2019.